Sarepta Gene Therapy Suspension - Search News

Order byBest matchMost fresh

News

Roche pauses Sarepta gene therapy shipments outside U.S.

FDA opens probe into mysterious death linked to gene therapy

The Food & Drug Administration is investigating the death of an 8‑year‑old following Elevidys gene therapy for Duchenne muscular dystrophy. U.S. distribution has been paused amid safety concerns.

Continue reading

· 4d · on MSN

In a reversal, Sarepta says it will pause shipments of gene therapy linked to deaths

Devdiscourse · 5d

Sarepta Suspends Gene Therapy Shipments After Tragic Deaths

21hon MSN

Two boys died after a gene therapy. This family won’t give up hope.

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...

11don MSN

Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients

Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best low priced pharma stocks to buy now. Towards the end of June, ...

Fierce Pharma3d

Roche halts Elevidys distribution in some countries, following Sarepta's lead in US

Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results